Peripheral Nerve Stimulators Market Size, Share and Report 2024-2031

Peripheral Nerve Stimulators Market Size, Outlook, Opportunities and Market Forecast 2024-2031

<h2>Global Peripheral Nerve Stimulators Market&nbsp;Size, Share &amp; Trends Analysis Report By Product, By Stimulating Feature, By End-user, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

&nbsp;

<h3>Market Overview</h3>

<blockquote>
The Global Peripheral Nerve Stimulators Market reached US$ 529.14 million in 2023 and is expected to reach US$ 977.11 million by 2031, growing at a CAGR of 8.2% during the forecast period 2024-2031.
</blockquote>

Peripheral nerve stimulators (PNS) are medical devices that use electrical currents to stimulate peripheral nerves. These nerves are located outside of the brain and spinal cord, and they connect the central nervous system to the muscles, skin, and other organs throughout the body.

These devices include transcutaneous PNS (TENS), implanted PNS, and percutaneous. PNS can be effective for pain from conditions like arthritis, low back pain, neuropathic pain (e.g., diabetic neuropathy), and post-surgical pain.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			&nbsp;8.2%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Stimulating Feature, End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/peripheral-nerve-stimulators-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Rising cases of peripheral nerve injuries

The rising prevalence of peripheral nerve injuries is expected to drive the market growth. Numerous incapacitating symptoms, including pain, weakness, and sensory loss, can be brought on by peripheral nerve injuries. There will be an increasing need for efficient treatment alternatives as the number of persons with PNIs increases. Healthcare practitioners can effectively manage these symptoms with PNS therapy since it provides a focused, non-surgical approach.

For instance, according to the report by the National Institute of Health in 2022, it stated that peripheral nerve injuries (PNI) are mainly caused by surgery and trauma and are common in clinical practice, with 13 to 23 per 1,00,000 people typically suffering from PNI. About 2.4% of people globally have a form of peripheral neuropathy. Thus, the above factors are expected to drive the market growth during the forecast period.&nbsp;

High cost of peripheral nerve stimulators&nbsp;&nbsp;

Peripheral nerve stimulators (PNS) are expensive, and this presents a big obstacle for the market&nbsp;that affects individuals and healthcare providers.&nbsp; The initial investment for PNS devices, particularly those with advanced features, can be substantial. Patients may find this burdensome, particularly if they are underfunded or do not have adequate insurance.

<h3>Segment Analysis</h3>

The global peripheral nerve stimulators market is segmented based on product, stimulating feature, end-user and region.

Transcutaneous peripheral nerve stimulators segment is expected to dominate the market growth

In the peripheral nerve stimulator (PNS) market, transcutaneous peripheral nerve stimulators (TENS) are the market leaders. Their units are considerably less expensive than implanted PNS devices. They are more accessible to a larger range of patients due to their affordability, especially those who are in settings with limited funds. Since TENS machines are frequently reusable, patients who need continuous therapy can save even more money over time.&nbsp;

The TENS machine is non-invasive. Without requiring surgery or skin bruising, electrodes are positioned on the skin&#39;s surface close to the afflicted area to provide electrical stimulation. They therefore have a convenient choice for individuals who might be wary of undergoing surgical procedures. TENS machines enable self-administered therapy since they are frequently portable and relatively easy to use. Patients are more likely to adhere to their treatment plans when this degree of ease is provided. Approved for use in post-operative pain treatment, labor&nbsp;pain management, and chronic pain conditions such as neuropathic pain, low back pain, and arthritis, TENS therapy is useful for several purposes.&nbsp;

When compared to implanted PNS devices, TENS units are typically categorized&nbsp;as medical devices with less stringent regulations. Greater innovation in this PNS market category is made possible by the ability of new TENS unit types to enter the market more quickly.&nbsp; Thus, the above factors are holding the segment in the dominant position in the market share

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the peripheral nerve stimulators market share 

North America has a high prevalence of chronic neurological conditions like chronic pain, movement disorders (Parkinson&#39;s disease, essential tremor), and urinary dysfunction. PNS treatment is well suited for treating these illnesses. North America&#39;s aging population significantly expands the possible patient pool for PNS devices.&nbsp;

North America has excellent hospitals, pain management clinics, and a sophisticated healthcare infrastructure. This makes it easier for medical practitioners to accept and operate PNS devices. The increasing prevalence of neurodegenerative disease increases the demand for peripheral nerve stimulators in the region.&nbsp;

For instance, according to the Parkinson&#39;s Foundation, nearly one million people in the U.S. are living with Parkinson&#39;s disease (PD). This number is expected to rise to 1.2 million by 2030. Parkinson&#39;s is the second-most common neurodegenerative disease after Alzheimer&#39;s disease. Nearly 90,000 people in the U.S. are diagnosed with PD each year.

The incidence of Parkinson&#39;s disease increases with age, but an estimated four percent of people with PD are diagnosed before age 50. Men are 1.5 times more likely to have Parkinson&#39;s disease than women. Thus, the above factors are expected to hold the region in the dominant position.

<h3>COVID-19 Impact Analysis</h3>

The supply chain for PNS devices and components has been restricted by global lockdowns and travel restrictions. This affected patient access to these devices by causing shortages and delivery delays.&nbsp;Several PNS implantations are regarded as elective surgeries.&nbsp; During the peak of the pandemic, hospitals gave priority to emergency care, which resulted in a substantial decline in PNS implantation procedures.&nbsp; This had an immediate effect on PNS device demand. The COVID-19 issue was being managed with the majority of healthcare resources.&nbsp; This took focus away from other medical conditions that would have benefited from PNS therapy, which could have delayed diagnoses.

<h3>Market Segmentation</h3>

By Product

<ul>
	<li>Transcutaneous</li>
	<li>Percutaneous</li>
	<li>Implantable&nbsp;</li>
</ul>

By Stimulating Feature

<ul>
	<li>PNS-TOF</li>
	<li>PNS</li>
</ul>

By End-User

<ul>
	<li>Hospitals</li>
	<li>Ambulatory Surgical Centers</li>
	<li>Specialty Clinics</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>Australia</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa&nbsp;&nbsp;</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Nalu Medical, Inc., B. Braun Melsungen AG, Teleflex Incorporated, Vygon SAS, Medtronic, Inc., Neuspera Medical and Medilogix among others.

<h3>Key Developments</h3>

<ul>
	<li>On April 18, 2023, Neuspera Medical received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system. The system is comprised of a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global peripheral nerve stimulators market segmentation based on product, stimulating feature, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of peripheral nerve stimulators market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global peripheral nerve stimulators market report would provide approximately 53 tables, 47 figures and 176 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Stimulating Feature</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising cases of peripheral nerve injuries</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High cost of peripheral nerve stimulators&nbsp;&nbsp;</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Transcutaneous*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Percutaneous</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Implantable</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Stimulating Feature</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
			<li>Market Attractiveness Index, By Stimulating Feature</li>
		</ol>
		</li>
		<li>PNS-TOF*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>PNS</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Ambulatory Surgical Centers</li>
		<li>Specialty Clinics</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulating Feature</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			</ol>
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Abbott Laboratories*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Becton Dickinson and Company</li>
		<li>Boston Scientific Corporation</li>
		<li>Nalu Medical, Inc.</li>
		<li>B. Braun Melsungen AG</li>
		<li>Teleflex Incorporated</li>
		<li>Vygon SAS</li>
		<li>Medtronic, Inc.</li>
		<li>Neuspera Medical</li>
		<li>Medilogix&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Peripheral Nerve Stimulators Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Peripheral Nerve Stimulators Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Peripheral Nerve Stimulators Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Peripheral Nerve Stimulators Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 7 Global Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 9 Global Peripheral Nerve Stimulators Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Peripheral Nerve Stimulators Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Peripheral Nerve Stimulators Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 14 North America Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 15 North America Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Peripheral Nerve Stimulators Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 18 South America Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 19 South America Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Peripheral Nerve Stimulators Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 22 Europe Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 23 Europe Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Peripheral Nerve Stimulators Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Peripheral Nerve Stimulators Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East &amp; Africa Peripheral Nerve Stimulators Market Value, By Product, 2022-2031 (US$ Million)

Table 30 Middle East &amp; Africa Peripheral Nerve Stimulators Market Value, By Stimulating Feature, 2022-2031 (US$ Million)

Table 31 Middle East &amp; Africa Peripheral Nerve Stimulators Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Abbott Laboratories: Overview

Table 33 Abbott Laboratories: Product Portfolio

Table 34 Abbott Laboratories: Key Developments

Table 35 Becton Dickinson and Company: Overview

Table 36 Becton Dickinson and Company: Product Portfolio

Table 37 Becton Dickinson and Company: Key Developments

Table 38 Boston Scientific Corporation: Overview

Table 39 Boston Scientific Corporation: Product Portfolio

Table 40 Boston Scientific Corporation: Key Developments

Table 41 Nalu Medical, Inc.: Overview

Table 42 Nalu Medical, Inc.: Product Portfolio

Table 43 Nalu Medical, Inc.: Key Developments

Table 44 B. Braun Melsungen AG: Overview

Table 45 B. Braun Melsungen AG: Product Portfolio

Table 46 B. Braun Melsungen AG: Key Developments

Table 47 Teleflex Incorporated: Overview

Table 48 Teleflex Incorporated: Product Portfolio

Table 49 Teleflex Incorporated: Key Developments

Table 50 Vygon SAS: Overview

Table 51 Vygon SAS: Product Portfolio

Table 52 Vygon SAS: Key Developments

Table 53 Medtronic, Inc.: Overview

Table 54 Medtronic, Inc.: Product Portfolio

Table 55 Medtronic, Inc.: Key Developments

Table 56 Neuspera Medical: Overview

Table 57 Neuspera Medical: Product Portfolio

Table 58 Neuspera Medical: Key Developments

Table 59 Medilogix: Overview

Table 60 Medilogix: Product Portfolio

Table 61 Medilogix: Key Developments

List of Figures

Figure 1 Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 2 Global Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 3 Global Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 4 Global Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 5 Global Peripheral Nerve Stimulators Market Share, By Region, 2023 &amp; 2031 (%)

Figure 6 Global Peripheral Nerve Stimulators Market Y-o-Y Growth, By Product, 2023-2031 (%)

Figure 7 Transcutaneous Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 8 Percutaneous Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 9 Implantable Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 10 Global Peripheral Nerve Stimulators Market Y-o-Y Growth, By Stimulating Feature, 2023-2031 (%)

Figure 11 PNS-TOF Stimulating Feature in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 12 PNS Stimulating Feature in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 13 Global Peripheral Nerve Stimulators Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 14 Hospitals End-User in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 15 Ambulatory Surgical Centers End-User in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 16 Specialty Clinics End-User in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 17 Others End-User in Global Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 18 Global Peripheral Nerve Stimulators Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 19 North America Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 20 Asia-Pacific Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 21 Europe Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 22 South America Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 23 Middle East and Africa Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 24 North America Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 25 North America Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 26 North America Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 27 North America Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 28 North America Peripheral Nerve Stimulators Market Share, By Country, 2023 &amp; 2031 (%)

Figure 29 South America Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 30 South America Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 31 South America Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 32 South America Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 33 South America Peripheral Nerve Stimulators Market Share, By Country, 2023 &amp; 2031 (%)

Figure 34 Europe Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 35 Europe Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 36 Europe Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 37 Europe Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 38 Europe Peripheral Nerve Stimulators Market Share, By Country, 2023 &amp; 2031 (%)

Figure 39 Asia-Pacific Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 40 Asia-Pacific Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 41 Asia-Pacific Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 42 Asia-Pacific Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 43 Asia-Pacific Peripheral Nerve Stimulators Market Share, By Country, 2023 &amp; 2031 (%)

Figure 44 Middle East &amp; Africa Peripheral Nerve Stimulators Market Value, 2022-2031 (US$ Million)

Figure 45 Middle East &amp; Africa Peripheral Nerve Stimulators Market Share, By Product, 2023 &amp; 2031 (%)

Figure 46 Middle East &amp; Africa Peripheral Nerve Stimulators Market Share, By Stimulating Feature, 2023 &amp; 2031 (%)

Figure 47 Middle East &amp; Africa Peripheral Nerve Stimulators Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 48 Abbott Laboratories: Financials

Figure 49 Becton Dickinson and Company: Financials

Figure 50 Boston Scientific Corporation: Financials

Figure 51 Nalu Medical, Inc.: Financials

Figure 52 B. Braun Melsungen AG: Financials

Figure 53 Teleflex Incorporated: Financials

Figure 54 Vygon SAS: Financials

Figure 55 Medtronic, Inc.: Financials

Figure 56 Neuspera Medical: Financials

Figure 57 Medilogix: Financials

Peripheral Nerve Stimulators Market Size, Outlook, Opportunities and Market Forecast 2024-2031

Neurovascular Embolization Devices Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 October 05

Starting from

Neuro Modulation Devices Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 October 05

Starting from

Neurorehabilitation Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 November 06

Starting from